Strata Critical Medical, Inc.
SRTANASDAQIndustrials● Active
$5.87
+$0.08(+1.38%)
Market Cap$507910966
P/E Ratio—
52W High$6.5
52W Low$3.51
Strata Critical Medical, Inc. (SRTA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SRTA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.03
Est. -$0.04 · +175.0%
Revenue
$0.07B
Est. $0.06B · +5.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
SRTA reports quarterly as a NASDAQ-listed Airlines, Airports & Air Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.04 | — | — | — | $0.07B | — |
| ▲ Q2 FY2026 | May 6, 2026 | -$0.04 | $0.03 | +175.0% | $0.07B | $0.06B | +5.8% |
| ▼ Q1 FY2026 | Mar 3, 2026 | $0.01 | -$0.06 | -721.4% | $0.07B | $0.06B | +10.7% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -$0.02 | -$0.06 | -200.0% | $0.05B | $0.06B | -18.3% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -$0.04 | -$0.05 | -25.0% | $0.07B | $0.08B | -11.4% |
| ▲ Q2 FY2025 | May 12, 2025 | -$0.11 | -$0.04 | +63.6% | $0.05B | $0.07B | -17.4% |
| — Q1 FY2025 | Mar 13, 2025 | -$0.12 | -$0.12 | +0.0% | $0.05B | $0.05B | +6.7% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.06 | -$0.03 | +50.0% | $0.07B | $0.05B | +45.3% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.04
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$0.03
EPS Est.
-$0.04
EPS Surpr.
+175.0%
Revenue
$0.07B
Q1 FY2026
Mar 3, 2026Miss
EPS Actual
-$0.06
EPS Est.
$0.01
EPS Surpr.
-721.4%
Revenue
$0.07B
Q4 FY2025
Nov 10, 2025Miss
EPS Actual
-$0.06
EPS Est.
-$0.02
EPS Surpr.
-200.0%
Revenue
$0.05B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
-$0.05
EPS Est.
-$0.04
EPS Surpr.
-25.0%
Revenue
$0.07B
Q2 FY2025
May 12, 2025Beat
EPS Actual
-$0.04
EPS Est.
-$0.11
EPS Surpr.
+63.6%
Revenue
$0.05B
Q1 FY2025
Mar 13, 2025
EPS Actual
-$0.12
EPS Est.
-$0.12
EPS Surpr.
+0.0%
Revenue
$0.05B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.03
EPS Est.
-$0.06
EPS Surpr.
+50.0%
Revenue
$0.07B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2026 | $-0.02 | $-0.01 | $-0.01 | 1 |
| Q3 FY2026 | $-0.02 | $-0.02 | $-0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +175.0% | $4.82 | $5.33 | +10.58% |
| ▼ Q1 FY2026 | Mar 3, 2026 | -721.4% | $4.49 | $4.80 | +6.90% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -200.0% | $4.43 | $4.85 | +9.48% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -25.0% | $4.43 | $4.16 | -6.09% |
| ▲ Q2 FY2025 | May 12, 2025 | +63.6% | $2.92 | $3.46 | +18.49% |
| ▲ Q1 FY2025 | Mar 13, 2025 | +0.0% | $2.83 | $3.03 | +7.07% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +50.0% | $3.83 | $3.49 | -8.88% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +0.0% | $2.77 | $2.77 | +0.00% |
Q2 FY2026+10.58%
Report Date
May 6, 2026
EPS Beat/Miss
+175.0%
Price Before
$4.82
Price After
$5.33
Q1 FY2026+6.90%
Report Date
Mar 3, 2026
EPS Beat/Miss
-721.4%
Price Before
$4.49
Price After
$4.80
Q4 FY2025+9.48%
Report Date
Nov 10, 2025
EPS Beat/Miss
-200.0%
Price Before
$4.43
Price After
$4.85
Q3 FY2025-6.09%
Report Date
Aug 5, 2025
EPS Beat/Miss
-25.0%
Price Before
$4.43
Price After
$4.16
Q2 FY2025+18.49%
Report Date
May 12, 2025
EPS Beat/Miss
+63.6%
Price Before
$2.92
Price After
$3.46
Q1 FY2025+7.07%
Report Date
Mar 13, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.83
Price After
$3.03
Q4 FY2024-8.88%
Report Date
Nov 12, 2024
EPS Beat/Miss
+50.0%
Price Before
$3.83
Price After
$3.49
Q3 FY2024+0.00%
Report Date
Aug 7, 2024
EPS Beat/Miss
+0.0%
Price Before
$2.77
Price After
$2.77
Avg Beat Reaction+5.45%
Avg Miss Reaction+3.43%
Beat Rate5 / 8 quarters
Largest Move+18.49% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SRTA ends December
Strata Critical Medical, Inc. (SRTA) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.03 — beating the analyst consensus of $-0.04 by +175.0%. The next SRTA earnings date is expected around September 1, 2026.
Each quarter, investors track SRTA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SRTA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SRTA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SRTA earnings · 5 questionsStrata Critical Medical, Inc.'s next earnings report is expected around September 1, 2026. SRTA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SRTA historically reports after market close (AMC).
SRTA earnings datewhen is SRTA earningsSRTA next earnings datewhen does SRTA report earningsSRTA earnings calendar
▸ Source: FMP · Strata Critical Medical, Inc. SEC filings · US GAAP · Strata Critical Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026